147 related articles for article (PubMed ID: 2089087)
1. Efficacy and safety of moclobemide compared with imipramine in the treatment of major depressive disorder. Double-blind multicenter study, Austria.
Hebenstreit GF; Loidl M; Baumhackl U; Gallhofer B; Geretsegger C; Radmayr E; Saletu M; Schöny W; Stabl M
J Neural Transm Suppl; 1990; 32():177-84. PubMed ID: 2089087
[TBL] [Abstract][Full Text] [Related]
2. Efficacy and tolerability of moclobemide compared with imipramine in depressive disorder (DSM-III): an Austrian double-blind, multicentre study.
Baumhackl U; Bizière K; Fischbach R; Geretsegger C; Hebenstreit G; Radmayr E; Stabl M
Br J Psychiatry Suppl; 1989 Oct; (6):78-83. PubMed ID: 2695130
[TBL] [Abstract][Full Text] [Related]
3. Efficacy and safety of moclobemide compared with maprotiline in treatment of major depressive disorder. A double-blind multicenter study with parallel groups.
Steinmeyer EM; Vorbach EU; Arnoldt KH
Pharmacopsychiatry; 1993 Nov; 26(6):246-53. PubMed ID: 8127929
[TBL] [Abstract][Full Text] [Related]
4. Double-blind comparison of moclobemide, imipramine and placebo in depressive patients.
Ucha Udabe R; Márquez CA; Traballi CA; Portes N
Acta Psychiatr Scand Suppl; 1990; 360():54-6. PubMed ID: 2123367
[TBL] [Abstract][Full Text] [Related]
5. Moclobemide, imipramine and placebo in the treatment of major depression.
Versiani M; Nardi AE; Mundim FD; Alves A; Schmid-Burgk W
Acta Psychiatr Scand Suppl; 1990; 360():57-8. PubMed ID: 2248073
[TBL] [Abstract][Full Text] [Related]
6. Moclobemide (Ro 11-1163) versus imipramine in the treatment of depression.
Casacchia M; Moll E
Acta Psychiatr Scand Suppl; 1990; 360():43. PubMed ID: 2248067
[TBL] [Abstract][Full Text] [Related]
7. A double-blind comparative trial of moclobemide v. imipramine and placebo in major depressive episodes.
Versiani M; Oggero U; Alterwain P; Capponi R; Dajas F; Heinze-Martin G; Marquez CA; Poleo MA; Rivero-Almanzor LE; Rossel L
Br J Psychiatry Suppl; 1989 Oct; (6):72-7. PubMed ID: 2695129
[TBL] [Abstract][Full Text] [Related]
8. Moclobemide and imipramine in chronic depression (dysthymia): an international double-blind, placebo-controlled trial. International Collaborative Study Group.
Versiani M; Amrein R; Stabl M
Int Clin Psychopharmacol; 1997 Jul; 12(4):183-93. PubMed ID: 9347378
[TBL] [Abstract][Full Text] [Related]
9. Moclobemide versus imipramine in depressed out-patients: a double-blind multi-centre study.
Rimón R; Jääskeläinen J; Kaartinen P; Kalli A; Kilponen E; Koskinen T; Nikkilä H; Pirttiperä V; Seppälä J
Int Clin Psychopharmacol; 1993 Jan; 7(3-4):141-7. PubMed ID: 8468435
[TBL] [Abstract][Full Text] [Related]
10. Efficacy of a reversible monoamine oxidase-A inhibitor versus imipramine in subgroups of depressed patients.
Bizière K; Berger M
Acta Psychiatr Scand Suppl; 1990; 360():59-60. PubMed ID: 2248074
[TBL] [Abstract][Full Text] [Related]
11. Moclobemide, imipramine, and placebo in the treatment of major depression (DSM III).
Versiani M; Nardi AE; Mundim FD; Alves AB
J Neural Transm Suppl; 1989; 28():65-75. PubMed ID: 2794994
[TBL] [Abstract][Full Text] [Related]
12. A multicentre comparative trial of moclobemide, imipramine and placebo in major depressive disorder. UK Moclobemide Study Group.
Int Clin Psychopharmacol; 1994; 9(2):109-13. PubMed ID: 8056992
[TBL] [Abstract][Full Text] [Related]
13. A controlled double-blind trial of moclobemide and imipramine in the treatment of depression.
Kok LP; Tsoi WF
Singapore Med J; 1995 Feb; 36(1):38-40. PubMed ID: 7570133
[TBL] [Abstract][Full Text] [Related]
14. Efficacy of reversible inhibitors of monoamine oxidase-A in various forms of depression.
Lecrubier Y; Guelfi JD
Acta Psychiatr Scand Suppl; 1990; 360():18-23. PubMed ID: 2248063
[TBL] [Abstract][Full Text] [Related]
15. Double-blind comparison of moclobemide and tranylcypromine in depression.
Heinze G; Rossel L; Gabelic I; Galeano-Munoz J; Stabl M; Allen SR
Pharmacopsychiatry; 1993 Nov; 26(6):240-5. PubMed ID: 8127928
[TBL] [Abstract][Full Text] [Related]
16. Effects of moclobemide on depressive symptoms and cognitive performance in a geriatric population: a controlled comparative study versus imipramine.
Pancheri P; Delle Chiaie R; Donnini M; Seripa S; Gambino C; Vicario E; Trillo L
Clin Neuropharmacol; 1994; 17 Suppl 1():S58-73. PubMed ID: 7954485
[TBL] [Abstract][Full Text] [Related]
17. Moclobemide versus clomipramine in the treatment of depression: a multicentre trial in Spain.
Civeira J; Cervera S; Giner J; Allen SR; Hellstern K; Malanowski H; Wirz R; Klar K
Acta Psychiatr Scand Suppl; 1990; 360():48-9. PubMed ID: 2248070
[TBL] [Abstract][Full Text] [Related]
18. Moclobemide and placebo in mild major depression: a double-blind randomized trial.
Ose E; Holm P
Psychopharmacology (Berl); 1992; 106 Suppl():S114-5. PubMed ID: 1546122
[TBL] [Abstract][Full Text] [Related]
19. Review of comparative clinical trials. Moclobemide vs tricyclic antidepressants and vs placebo in depressive states.
Stabl M; Biziére K; Schmid-Burgk W; Amrein R
J Neural Transm Suppl; 1989; 28():77-89. PubMed ID: 2677244
[TBL] [Abstract][Full Text] [Related]
20. Moclobemide versus clomipramine in the treatment of depression: a double-blind multicentre study in Belgium.
Dierick M; Cattiez P; Franck G; Burton P; Defleur J; Hermans W; Roelandts A; Wolfrum C; Berger M; Hellstern K
Acta Psychiatr Scand Suppl; 1990; 360():50-1. PubMed ID: 2248071
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
